Skip to main content
. 2016 Mar 29;39(5):764–771. doi: 10.2337/dc15-2230

Table 1.

Characteristics at the time of enrollment into the Look AHEAD trial of participants who had successful MRI scans in the Look AHEAD Brain study, by intervention assignment

DSE (n = 155) ILI (n = 164) P value
Age, years 0.50
 45–54 44 (28.4) 40 (24.4)
 55–64 91 (58.7) 96 (58.5)
 65–76 20 (12.9) 28 (17.1)
Female sex 114 (73.5) 110 (67.1) 0.21
Race/ethnicity 0.70
 African American 37 (23.9) 33 (20.1)
 Non-Hispanic white 110 (71.0) 123 (75.0)
 Other/multiple 8 (5.2) 8 (4.9)
Education, years 0.61
 <13 24 (16.1) 30 (18.8)
 13–16 58 (38.9) 54 (33.8)
 >16 67 (45.0) 76 (47.5)
BMI, kg/m2 0.046
 25–29 18 (11.6) 32 (19.5)
 30–39 99 (63.9) 106 (64.6)
 ≥40 38 (24.5) 26 (15.9)
HbA1c, % (mmol/mol) 0.58
 <7.0 (53) 65 (42.5) 73 (44.8)
 7.0–8.9 (53–74) 75 (49.0) 81 (49.7)
 ≥9.0 (75) 13 (8.5) 9 (5.5)
Diabetes duration, years 0.97
 <5 73 (47.7) 76 (47.5)
 ≥5 80 (52.3) 84 (52.5)
Insulin use 20 (13.6) 18 (11.5) 0.57
Hypertension 129 (83.2) 135 (82.3) 0.83
Prior cardiovascular disease 13 (8.4) 13 (7.9) 0.88
Depressive symptoms 0.77
 BDI score <11 135 (87.7) 142 (86.6)
 BDI score ≥11 19 (12.3) 22 (13.4)
Antidepressant use 28 (19.0) 32 (20.4) 0.77
Alcohol intake, drinks/day 0.56
 <1 143 (92.3) 154 (93.9)
 ≥1 12 (7.7) 10 (6.1)
Baseline smoking status 0.97
 Never 77 (49.7) 83 (50.9)
 Past 72 (46.5) 74 (45.4)
 Current 6 (3.9) 6 (3.7)
Fitness, METs 0.07
 <7.1 84 (54.2) 72 (43.9)
 ≥7.1 71 (45.8) 92 (56.1)
Paffenbarger activity questionnaire score 0.72
 <1,060 73 (47.1) 70 (42.7)
 ≥1,060 35 (22.6) 41 (25.0)
 Not collected 47 (30.3) 53 (32.3)
ApoE4 alleles, n 0.008
 0 110 (71.0) 100 (61.0)
 1 22 (14.2) 47 (28.7)
 2 2 (1.3) 0 (0.0)
 Not collected 21 (13.6) 17 (10.4)

Data are n (%) unless otherwise indicated. No participants had a history of stroke at enrollment in the Look AHEAD trial. BDI, Beck Depression Inventory.